LOGIN  |  REGISTER

List of Medical Stocks

Company
Last Trade
Change
Volume
Shares Out
Market Cap
US$ 501.48
-3.41 -0.68
1.35M
385.95M
US$ 193.550B
US$ 249.62
-4.84 -1.90
2.00M
738.35M
US$ 184.310B
US$ 98.93
-1.35 -1.35
3.08M
1.74B
US$ 172.140B
US$ 284.31
-4.66 -1.61
726,506
379.78M
US$ 107.980B
US$ 80.46
-1.02 -1.25
4.85M
1.33B
US$ 107.010B
US$ 284.35
-7.61 -2.61
1.94M
351.36M
US$ 99.910B
US$ 53.98
-0.12 -0.22
9.02M
1.46B
US$ 78.810B
US$ 265.11
-2.02 -0.76
779,147
290.11M
US$ 76.910B
US$ 438.10
-1.76 -0.40
648,385
134.90M
US$ 59.100B
US$ 70.18
-1.77 -2.46
2.60M
607.92M
US$ 42.660B
US$ 78.38
-1.80 -2.24
719,694
491.80M
US$ 38.550B
US$ 199.17
-6.25 -3.04
1.36M
183.12M
US$ 36.470B
US$ 438.65
-16.70 -3.67
521,509
83.01M
US$ 36.410B
US$ 179.97
0.00 0.00
0
200.85M
US$ 36.150B
US$ 89.08
-3.55 -3.83
4.88M
387.87M
US$ 34.550B
US$ 109.74
-2.73 -2.43
1.10M
292.59M
US$ 32.110B
US$ 374.47
-9.87 -2.57
295,772
73.86M
US$ 27.660B
US$ 117.80
-2.51 -2.09
1.03M
208.96M
US$ 24.620B
US$ 1.00
-37.14 -3.28
122,605
21.86M
US$ 23.910B
US$ 300.28
-9.22 -2.98
803,019
76.53M
US$ 22.980B
US$ 89.09
-0.28 -0.31
1.68M
250.68M
US$ 22.330B
US$ 220.58
-4.69 -2.08
284,159
98.78M
US$ 21.790B
US$ 133.33
-5.02 -3.63
1.51M
158.30M
US$ 21.110B
US$ 251.87
-9.91 -3.79
623,667
82.15M
US$ 20.690B
US$ 136.33
-4.79 -3.39
1.35M
147.07M
US$ 20.050B
US$ 38.12
-0.35 -0.91
3.47M
506.40M
US$ 19.300B
US$ 205.19
-0.01 0.00
898,676
88.60M
US$ 18.180B
US$ 70.07
-1.38 -1.93
1.31M
244.94M
US$ 17.160B
US$ 328.42
-8.20 -2.44
132,567
49.52M
US$ 16.260B
US$ 268.78
-5.33 -1.94
246,889
59.10M
US$ 15.880B
US$ 115.24
0.00 0.00
0
125.44M
US$ 14.460B
US$ 123.49
-1.52 -1.22
752,778
112.24M
US$ 13.860B
US$ 108.50
-1.91 -1.73
498,165
124.14M
US$ 13.470B
US$ 69.53
-3.42 -4.69
2.17M
180.66M
US$ 12.560B
US$ 159.93
-4.81 -2.92
1.21M
69.82M
US$ 11.170B
US$ 25.42
-0.38 -1.47
1.17M
436.70M
US$ 11.100B
US$ 198.18
-10.45 -5.01
1.16M
51.27M
US$ 10.160B
US$ 250.43
-12.00 -4.57
217,076
38.44M
US$ 9.630B
US$ 73.69
-0.78 -1.05
477,201
130.58M
US$ 9.620B
US$ 203.42
-5.32 -2.55
144,745
46.99M
US$ 9.560B
US$ 62.18
-1.98 -3.09
924,662
146.85M
US$ 9.130B
US$ 39.59
-0.78 -1.93
1.05M
228.18M
US$ 9.030B
US$ 161.72
-6.86 -4.07
443,260
55.76M
US$ 9.020B
US$ 357.62
-6.80 -1.87
125,673
24.00M
US$ 8.580B
US$ 240.81
-13.89 -5.45
488,288
30.56M
US$ 7.360B
US$ 196.88
-7.19 -3.52
456,266
36.75M
US$ 7.240B
US$ 34.16
-1.03 -2.93
1.50M
211.72M
US$ 7.230B
US$ 51.09
-1.77 -3.35
921,501
117.35M
US$ 5.990B
US$ 16.82
-0.45 -2.61
292,030
350.70M
US$ 5.900B
US$ 47.29
-1.87 -3.80
1.59M
119.15M
US$ 5.630B
US$ 191.30
-8.52 -4.26
466,405
29.34M
US$ 5.610B
US$ 97.03
-2.84 -2.84
454,572
52.82M
US$ 5.130B
US$ 71.82
-1.63 -2.22
661,693
66.79M
US$ 4.800B
US$ 90.06
-1.75 -1.91
263,034
50.71M
US$ 4.570B
US$ 27.55
-0.65 -2.30
1.28M
163.82M
US$ 4.510B
US$ 42.77
-0.01 -0.02
875,837
103.72M
US$ 4.440B
US$ 15.14
-0.17 -1.11
666,071
282.62M
US$ 4.280B
US$ 19.31
-0.59 -2.96
841,839
216.31M
US$ 4.180B
US$ 60.27
-1.69 -2.73
929,142
68.43M
US$ 4.120B
US$ 67.99
-0.51 -0.74
316,528
57.64M
US$ 3.920B
US$ 65.47
-0.91 -1.37
418,501
57.35M
US$ 3.750B
US$ 75.26
-0.51 -0.67
512,278
48.65M
US$ 3.660B
US$ 38.72
-0.20 -0.51
436,154
81.40M
US$ 3.150B
US$ 101.46
-4.65 -4.38
273,278
30.74M
US$ 3.120B
US$ 26.11
-1.31 -4.78
1.44M
117.69M
US$ 3.070B
US$ 55.79
-1.31 -2.29
230,479
53.88M
US$ 3.010B
US$ 48.66
-0.95 -1.91
505,362
59.20M
US$ 2.880B
US$ 57.45
-0.51 -0.88
101,405
49.54M
US$ 2.850B
US$ 116.90
-4.30 -3.55
110,322
24.14M
US$ 2.820B
US$ 29.28
-0.01 -0.03
569,322
95.85M
US$ 2.810B
US$ 55.42
-3.33 -5.67
462,118
50.46M
US$ 2.800B
US$ 32.25
-0.82 -2.48
1.14M
83.23M
US$ 2.680B
US$ 87.30
-2.07 -2.32
392,382
30.58M
US$ 2.670B
US$ 78.86
-1.03 -1.29
143,378
33.31M
US$ 2.630B
US$ 47.55
0.00 0.00
0
47.76M
US$ 2.270B
US$ 9.00
-0.43 -4.56
4.49M
250.56M
US$ 2.260B
US$ 39.75
0.00 0.00
0
52.45M
US$ 2.080B
US$ 41.74
0.01 0.02
327,667
47.35M
US$ 1.980B
US$ 39.39
-1.28 -3.15
628,811
48.50M
US$ 1.910B
US$ 17.59
-0.19 -1.07
1.36M
106.62M
US$ 1.880B
US$ 57.06
-0.41 -0.71
576,577
32.63M
US$ 1.860B
US$ 27.30
-0.76 -2.71
405,972
67.77M
US$ 1.850B
US$ 14.59
-0.16 -1.08
136,878
124.34M
US$ 1.810B
US$ 32.09
-0.46 -1.41
274,791
50.36M
US$ 1.620B
US$ 12.20
-0.28 -2.24
753,295
127.55M
US$ 1.560B
US$ 12.42
-0.76 -5.77
2.31M
120.32M
US$ 1.490B
US$ 21.24
-1.53 -6.72
787,151
65.08M
US$ 1.380B
US$ 16.77
-0.23 -1.35
448,839
81.88M
US$ 1.370B
US$ 119.99
0.00 0.00
0
10.91M
US$ 1.310B
US$ 57.03
-0.46 -0.80
95,881
22.26M
US$ 1.270B
US$ 1.62
-0.02 -1.22
2.12M
773.06M
US$ 1.250B
US$ 48.22
-1.00 -2.03
139,868
25.78M
US$ 1.240B
US$ 15.69
-0.37 -2.30
880,758
76.53M
US$ 1.200B
US$ 8.66
-0.28 -3.13
2.10M
136.11M
US$ 1.180B
US$ 12.15
-0.02 -0.16
988,374
97.39M
US$ 1.180B
US$ 46.78
0.20 0.43
31,100
24.57M
US$ 1.150B
US$ 19.68
-0.52 -2.57
771,465
57.40M
US$ 1.130B
US$ 13.05
-0.23 -1.73
353,982
82.55M
US$ 1.080B
US$ 27.41
-0.95 -3.35
384,665
35.64M
US$ 976.890M
US$ 27.38
-0.46 -1.65
277,576
34.87M
US$ 954.740M
US$ 20.10
-0.23 -1.13
189,773
46.87M
US$ 942.090M
US$ 24.98
-0.60 -2.35
293,459
37.55M
US$ 938.000M
US$ 7.70
-0.08 -1.03
374,731
116.11M
US$ 894.050M
US$ 6.40
0.07 1.11
463,139
136.36M
US$ 872.700M
US$ 21.21
-0.66 -3.02
165,090
40.20M
US$ 852.640M
US$ 27.67
-0.20 -0.72
187,567
29.93M
US$ 828.160M
US$ 13.43
-0.46 -3.31
377,629
61.54M
US$ 826.480M
US$ 440.98
-3.05 -0.69
3,863
1.76M
US$ 776.120M
US$ 32.37
-0.72 -2.18
48,151
23.35M
US$ 755.840M
US$ 18.54
0.24 1.31
197,954
40.40M
US$ 749.020M
US$ 19.52
-0.50 -2.50
453,167
36.12M
US$ 705.060M
US$ 15.05
0.09 0.60
107,879
41.04M
US$ 617.650M
US$ 15.68
-0.30 -1.88
717,102
38.83M
US$ 608.850M
US$ 11.25
-0.58 -4.90
378,118
49.79M
US$ 560.140M
US$ 43.92
-0.27 -0.61
15,259
12.60M
US$ 553.390M
US$ 12.68
-0.02 -0.16
370,916
43.49M
US$ 551.450M
US$ 12.70
-0.03 -0.24
563,668
36.74M
US$ 466.600M
US$ 16.66
-0.28 -1.65
94,406
26.81M
US$ 446.650M
US$ 7.75
-0.09 -1.15
629,957
54.17M
US$ 419.820M
US$ 5.61
0.18 3.31
697,351
73.41M
US$ 411.830M
US$ 10.50
-0.05 -0.47
240,783
38.03M
US$ 399.320M
US$ 6.45
-0.07 -1.07
578,178
55.56M
US$ 358.360M
US$ 13.86
-0.28 -1.98
106,761
25.48M
US$ 353.150M
US$ 3.20
0.03 0.95
697,487
103.50M
US$ 331.200M
US$ 13.30
-0.37 -2.71
390,908
23.46M
US$ 312.020M
US$ 1.01
0.01 1.49
1.82M
304.93M
US$ 307.980M
US$ 83.86
-1.79 -2.09
5,631
3.63M
US$ 304.410M
US$ 14.65
-0.41 -2.72
37,730
20.76M
US$ 304.130M
US$ 8.37
0.34 4.23
458,204
35.10M
US$ 293.790M
US$ 34.16
-0.23 -0.67
3,277
8.52M
US$ 291.040M
US$ 0.54
0.02 3.79
6.32M
528.18M
US$ 285.060M
US$ 7.11
0.00 0.00
516,879
39.67M
US$ 282.050M
US$ 7.10
-0.05 -0.70
130,651
38.40M
US$ 272.640M
US$ 2.70
-0.04 -1.46
260,682
96.59M
US$ 260.790M
US$ 9.59
-0.31 -3.13
145,488
26.53M
US$ 254.420M
US$ 5.47
0.06 1.11
574,773
46.50M
US$ 254.360M
US$ 1.98
-0.03 -1.49
744,548
121.78M
US$ 241.120M
US$ 6.43
-0.18 -2.72
99,118
36.93M
US$ 237.460M
US$ 4.12
-0.15 -3.51
86,693
54.90M
US$ 226.190M
US$ 5.28
-0.17 -3.12
90,869
42.08M
US$ 222.180M
US$ 1.22
0.06 4.74
5.30M
180.21M
US$ 218.960M
US$ 2.73
-0.05 -1.80
231,319
78.96M
US$ 215.560M
US$ 4.99
-0.21 -4.04
227,853
42.98M
US$ 214.470M
US$ 4.38
-0.07 -1.57
160,699
48.94M
US$ 214.360M
C$ 1.45
0.00 0.00
0
146.82M
C$ 212.890M
US$ 7.35
-0.16 -2.13
8,146
28.67M
US$ 210.720M
US$ 9.89
-0.02 -0.20
20,021
21.26M
US$ 210.260M
US$ 9.82
0.01 0.10
29,577
21.05M
US$ 206.710M
US$ 7.80
-0.10 -1.27
25,336
25.86M
US$ 201.710M
US$ 8.20
0.10 1.23
316,519
24.49M
US$ 200.820M
US$ 6.00
-0.04 -0.66
165,267
32.33M
US$ 193.980M
US$ 0.70
-0.03 -4.64
11.76M
270.45M
US$ 189.040M
US$ 26.89
-0.45 -1.65
54,437
6.87M
US$ 184.730M
US$ 2.91
-0.16 -5.21
218,458
62.79M
US$ 182.720M
US$ 4.12
0.02 0.49
129,052
42.69M
US$ 175.880M
US$ 9.40
0.00 0.00
0
17.27M
US$ 162.340M
US$ 7.89
-0.41 -4.94
646,009
19.94M
US$ 157.330M
US$ 5.59
0.09 1.64
16,178
26.40M
US$ 147.580M
US$ 2.96
0.08 2.78
345,323
48.65M
US$ 144.000M
US$ 1.77
-0.005 -0.28
71,449
80.87M
US$ 142.740M
US$ 1.09
-0.05 -4.39
115,739
128.90M
US$ 140.500M
US$ 2.92
-0.17 -5.36
51,141
45.64M
US$ 133.040M
US$ 16.10
-0.91 -5.35
47,493
7.75M
US$ 124.780M
US$ 5.15
-0.05 -0.96
244,526
23.19M
US$ 119.430M
US$ 1.48
0.02 1.37
50,699
78.61M
US$ 116.340M
US$ 3.33
-0.18 -5.00
99,715
34.64M
US$ 115.180M
US$ 0.75
-0.03 -3.61
277,052
152.68M
US$ 114.430M
US$ 1.99
-0.04 -1.97
120,196
56.29M
US$ 112.020M
C$ 0.39
0.02 4.05
72,000
278.58M
C$ 107.250M
US$ 2.98
-0.02 -0.67
588,014
35.35M
US$ 105.340M
US$ 15.93
-0.09 -0.56
12,553
6.54M
US$ 104.180M
US$ 0.29
-0.01 -3.94
65.62M
333.58M
US$ 96.670M
US$ 0.94
-0.07 -6.50
16,503
102.68M
US$ 96.010M
C$ 1.42
-0.03 -2.07
22,900
64.58M
C$ 91.700M
US$ 2.02
0.01 0.50
20,077
44.36M
US$ 89.610M
US$ 2.80
-0.03 -1.06
271,773
31.71M
US$ 88.790M
US$ 10.31
0.04 0.39
11,192
8.56M
US$ 88.250M
US$ 2.99
-0.08 -2.61
25,352
29.25M
US$ 87.460M
US$ 3.13
0.09 2.96
119,454
27.23M
US$ 85.230M
US$ 0.90
0.01 1.24
51,731
91.55M
US$ 82.400M
US$ 0.29
-0.01 -4.03
583,378
280.57M
US$ 80.780M
US$ 1.00
-0.06 -5.66
109,727
78.14M
US$ 78.140M
US$ 3.01
-0.05 -1.63
268,009
25.78M
US$ 77.600M
US$ 5.28
-0.19 -3.47
18,712
14.37M
US$ 75.870M
US$ 0.28
-0.01 -3.62
2.16M
263.88M
US$ 73.120M
US$ 2.70
-0.13 -4.59
53,324
27.04M
US$ 73.010M
US$ 3.38
0.22 6.96
32,736
21.20M
US$ 71.660M
US$ 4.26
-0.35 -7.59
117,796
16.60M
US$ 70.720M
US$ 0.97
-0.01 -1.39
79,390
71.37M
US$ 69.220M
US$ 1.36
-0.03 -2.16
50,939
49.73M
US$ 67.630M
US$ 2.12
-0.06 -2.75
24,867
30.64M
US$ 64.960M
US$ 4.16
-0.20 -4.59
396,897
15.28M
US$ 63.560M
US$ 1.44
-0.01 -0.69
12,278
43.73M
US$ 62.970M
US$ 2.27
-0.10 -4.22
30,937
26.31M
US$ 59.720M
US$ 1.70
0.01 0.59
124,133
33.68M
US$ 57.260M
US$ 15.81
0.01 0.06
1,766
3.55M
US$ 56.130M
US$ 1.78
-0.05 -2.73
3,431
29.88M
US$ 53.190M
C$ 0.52
0.02 4.00
4,000
101.40M
C$ 52.730M
US$ 5.42
-0.25 -4.41
41,815
9.47M
US$ 51.330M
C$ 0.23
0.00 0.00
74,500
223.14M
C$ 51.320M
US$ 0.31
-0.01 -3.12
44,636
164.32M
US$ 50.940M
US$ 3.15
-0.10 -3.08
20,744
15.63M
US$ 49.230M
US$ 0.94
0.05 5.45
28,180
50.82M
US$ 47.760M
US$ 4.57
-0.53 -10.39
38,258
10.20M
US$ 46.610M
US$ 2.23
-0.22 -8.98
20,074
20.75M
US$ 46.270M
US$ 0.76
-0.02 -2.48
131,536
59.94M
US$ 45.550M
US$ 1.87
-0.28 -13.02
40,812
23.94M
US$ 44.770M
US$ 0.57
0.04 7.72
256,093
76.87M
US$ 43.890M
US$ 2.64
-0.06 -2.22
71,767
16.39M
US$ 43.270M
US$ 1.14
0.03 2.70
17,188
37.02M
US$ 42.200M
US$ 0.80
-0.02 -2.43
30,341
52.69M
US$ 42.160M
US$ 2.42
0.09 3.86
13,015
16.86M
US$ 40.800M
US$ 1.33
-0.03 -2.21
111,382
28.87M
US$ 38.400M
C$ 0.31
0.00 0.00
0
121.19M
C$ 36.960M
US$ 1.23
0.04 3.36
6,780
29.95M
US$ 36.840M
US$ 1.21
0.01 0.83
47,148
29.94M
US$ 36.230M
US$ 3.19
0.00 0.00
1,050
11.25M
US$ 35.890M
US$ 0.32
0.0082 2.63
929,302
111.42M
US$ 35.650M
US$ 2.20
0.08 3.54
77,677
16.23M
US$ 35.620M
C$ 0.35
-0.01 -2.78
12,000
101.39M
C$ 35.490M
US$ 3.13
0.14 4.68
254,054
11.26M
US$ 35.240M
US$ 5.49
0.05 0.92
3,089
6.00M
US$ 32.940M
US$ 1.05
0.02 1.94
71,224
30.79M
US$ 32.330M
C$ 0.21
-0.005 -2.38
141,020
156.82M
C$ 32.150M
US$ 3.65
-0.13 -3.44
3,697
8.48M
US$ 30.950M
US$ 1.10
0.02 1.85
9,819
27.87M
US$ 30.660M
US$ 0.66
0.09 14.78
568,731
45.62M
US$ 30.110M
US$ 0.39
0.02 6.24
134,049
73.13M
US$ 28.740M
US$ 1.06
-0.02 -1.85
305,575
26.51M
US$ 28.100M
US$ 0.73
0.04 5.65
11,262
38.21M
US$ 27.860M
C$ 0.38
0.005 1.35
3,100
69.23M
C$ 25.960M
C$ 0.48
0.02 3.23
69,304
52.64M
C$ 25.270M
US$ 1.17
0.02 1.74
65,464
21.10M
US$ 24.690M
US$ 0.70
0.04 6.43
19,660
34.91M
US$ 24.560M
US$ 1.78
0.06 3.49
2,165
13.76M
US$ 24.490M
US$ 4.05
0.23 6.02
224,017
5.85M
US$ 23.690M
C$ 0.27
-0.01 -3.57
21,900
83.29M
C$ 22.490M
US$ 0.91
-0.01 -1.29
32,709
23.92M
US$ 21.720M
US$ 0.06
-0.003 -5.01
88,169
370.54M
US$ 21.080M
US$ 3.66
-0.07 -1.88
17,297
5.74M
US$ 21.010M
C$ 0.21
0.00 0.00
1,985
99.64M
C$ 20.430M
US$ 0.70
0.08 12.16
92,088
29.26M
US$ 20.350M
US$ 2.21
0.03 1.38
26,935
8.32M
US$ 18.390M
US$ 0.45
0.00 0.00
0
40.60M
US$ 18.360M
US$ 1.32
0.05 3.94
21,210
13.66M
US$ 18.030M
US$ 2.27
0.00 0.00
0
7.88M
US$ 17.890M
US$ 1.05
-0.04 -3.67
90,763
16.82M
US$ 17.660M
C$ 0.24
-0.02 -7.69
1,000
71.16M
C$ 17.080M
US$ 2.76
-0.24 -8.00
49,424
6.13M
US$ 16.920M
C$ 0.10
-0.01 -9.52
647,099
171.29M
C$ 16.270M
US$ 0.22
0.00 0.00
0
73.90M
US$ 16.250M
US$ 1.38
-0.05 -3.29
34,733
11.70M
US$ 16.150M
US$ 0.84
-0.02 -1.89
41,966
19.24M
US$ 16.140M
US$ 1.38
-0.03 -1.79
126,447
11.71M
US$ 16.100M
US$ 1.00
0.03 3.06
23,340
16.06M
US$ 16.060M
C$ 0.27
-0.01 -3.57
17,500
56.42M
C$ 15.230M
US$ 1.42
0.01 0.71
10,787
10.48M
US$ 14.880M
C$ 0.07
0.00 0.00
10,000
188.08M
C$ 13.170M
US$ 3.21
0.04 1.26
17,600
4.03M
US$ 12.940M
C$ 0.24
0.00 0.00
0
51.86M
C$ 12.450M
US$ 1.42
-0.08 -5.33
45,073
8.72M
US$ 12.380M
US$ 2.05
-0.05 -2.38
2,781
5.70M
US$ 11.680M
US$ 2.54
-0.06 -2.31
69,542
4.57M
US$ 11.610M
US$ 0.39
-0.0001 -0.03
149,184
28.90M
US$ 11.190M
US$ 2.02
-0.19 -8.65
5,493
5.53M
US$ 11.170M
US$ 0.02
0.00 0.00
6,100
548.74M
US$ 10.870M
US$ 5.80
-0.10 -1.69
4,466
1.82M
US$ 10.560M
C$ 0.04
-0.005 -11.11
28,000
246.29M
C$ 9.850M
US$ 0.69
-0.02 -2.96
31,572
13.81M
US$ 9.480M
US$ 1.06
-0.48 -31.17
36,696
8.78M
US$ 9.310M
US$ 1.13
-0.04 -3.42
68,793
7.48M
US$ 8.450M
US$ 11.18
-2.61 -18.93
7.16M
717,025
US$ 8.020M
US$ 0.10
-0.0017 -1.65
5,250
77.41M
US$ 7.840M
C$ 0.08
0.00 0.00
0
94.42M
C$ 7.550M
C$ 0.06
0.00 0.00
403,318
122.72M
C$ 7.360M
US$ 0.27
-0.03 -10.41
807,618
27.56M
US$ 7.310M
US$ 0.56
0.008 1.45
68,216
11.66M
US$ 6.530M
US$ 0.21
-0.04 -16.81
442,068
29.93M
US$ 6.220M
US$ 0.67
-0.05 -7.19
12,620
9.07M
US$ 6.080M
US$ 0.68
-0.0037 -0.54
13,347
8.59M
US$ 5.880M
US$ 4.72
-0.03 -0.63
1.37M
1.24M
US$ 5.850M
US$ 0.24
-0.02 -6.00
73,338
24.84M
US$ 5.840M
US$ 14.31
-0.97 -6.35
45,235
380,648
US$ 5.450M
US$ 0.45
0.00 0.00
0
11.77M
US$ 5.270M
US$ 8.67
0.09 1.05
55,067
565,968
US$ 4.910M
US$ 0.55
0.00 0.00
0
8.48M
US$ 4.690M
US$ 0.31
-0.02 -4.93
141,461
15.07M
US$ 4.620M
US$ 0.03
0.00 0.00
0
183.40M
US$ 4.580M
US$ 0.37
-0.0074 -1.94
162,883
10.92M
US$ 4.080M
US$ 1.42
-0.06 -4.05
103,851
2.63M
US$ 3.730M
C$ 0.03
0.005 20.00
22,580
118.77M
C$ 3.560M
US$ 0.15
-0.007 -4.38
442,185
22.61M
US$ 3.460M
US$ 0.51
-0.04 -6.92
45,210
6.46M
US$ 3.280M
US$ 0.43
-0.01 -2.28
1,918
7.44M
US$ 3.190M
US$ 2.15
0.00 0.00
56,479
1.47M
US$ 3.160M
US$ 1.27
0.05 4.09
18,680
2.33M
US$ 2.960M
US$ 1.17
-0.03 -2.50
2,362
2.48M
US$ 2.900M
US$ 0.70
-0.04 -5.14
2,895
4.04M
US$ 2.830M
US$ 1.52
-0.11 -6.75
21,604
1.86M
US$ 2.830M
US$ 0.48
0.02 3.94
12,045
5.89M
US$ 2.830M
US$ 1.00
-0.01 -0.99
20,305
2.47M
US$ 2.470M
US$ 0.76
0.0028 0.37
50,309
3.13M
US$ 2.390M
US$ 0.61
-0.06 -9.33
143,420
3.45M
US$ 2.110M
C$ 0.06
0.01 20.00
5,000
34.03M
C$ 2.040M
US$ 0.23
-0.02 -7.29
193,501
8.90M
US$ 2.000M
US$ 1.74
0.03 1.75
2.19M
1.04M
US$ 1.810M
US$ 0.18
0.00 0.00
0
9.18M
US$ 1.680M
US$ 0.18
0.00 0.00
0
7.44M
US$ 1.350M
US$ 0.48
0.00 0.00
0
2.21M
US$ 1.060M
US$ 0.75
0.00 0.00
0
1.24M
US$ 930K
US$ 0.09
0.00 0.00
0
9.32M
US$ 871K
US$ 0.0008
-0.0001 -11.11
505,000
309.68M
US$ 248K
US$ 0.004
0.00 0.00
0
4.01M
US$ 16K
US$ 1.53
0.00 0.00
170,418
-
US$ -
US$ 1.10
0.00 0.00
15,538
-
US$ -
US$ 0.47
-0.02 -4.08
20,946
-
US$ -
US$ 0.53
0.00 0.00
0
-
US$ -

Latest News From Medical Stocks


QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA

SAN DIEGO / Sep 21, 2023 / Business Wire / QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it has been granted CLIA Waiver from the U.S. Food and Drug Administration (FDA), applying to its new Sofia® 2 SARS Antigen+ FIA. The Sofia 2 SARS Antigen+ FIA is the first rapid antigen test that detects COVID-19... Read more


Stryker's Triathlon Tritanium Baseplate marks a decade of positive patient impact

Over 1 million Triathlon Cementless Knees implanted globally MAHWAH, N.J., Sept. 21, 2023 /PRNewswire/ -- Stryker (NYSE: SYK), one of the world's leading medical technology companies, continues its year of milestones celebration with the 10th anniversary of the Triathlon Tritanium baseplate. Since its introduction in 2013, Triathlon Cementless, which includes the Triathlon Tritanium Baseplate, has delivered a decade of positive patient impact, demonstrated impressive... Read more


Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide™ Assay to Evaluate Patients with Leptomeningeal Metastases

SAN DIEGO / Sep 21, 2023 / Business Wire / Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces the full enrollment of 40 subjects with breast or non-small cell lung cancer (NSCLC) who have suspicious or confirmed leptomeningeal metastases (LM) in the feasibility phase of its prospective FORESEE clinical trial (NCT0414123). This trial is evaluating the performance of Biocept’s proprietary CNSide assay in monitoring... Read more


Dexcom Canada and RxFood Partner on Industry-Leading, AI-powered Nutrition and Glucose Monitoring Solution for Diabetes Management and Personalized Therapeutic Nutrition

The partnership will pair cutting-edge technology from Dexcom with daily food tracking to provide a more comprehensive and personalized care experience for those living with diabetes BURNABY, British Columbia / Sep 21, 2023 / Business Wire / Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, and RxFood Corporation, the leader in AI-driven personalized nutrition assessments, announced today a firs... Read more


Medtronic Diabetes announces CE Mark for new Simplera™ CGM with disposable all-in-one design

The company's newest Simplera™ CGM is 50% smaller than its previous generation with a simple insertion and improved user experience DUBLIN, Sept. 21, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced CE (Conformité Européenne) Mark approval for its new all-in-one, disposable Simplera™ continuous glucose monitor (CGM) featuring a simple, two-step insertion process. The company's newest no-fingerstick... Read more


Digital Dentistry: Dentsply Sirona and 3Shape expand their workflow integrations

Dentsply Sirona and 3Shape are expanding their workflow integrations to enable dental professionals through DS Core and 3Shape Unite to use a scan-to-lab workflow or establish design and manufacturing protocols directly in their practice. CHARLOTTE, N.C. and COPENHAGEN, Denmark, Sept. 21, 2023 /PRNewswire/ -- Dentsply Sirona, the world's largest manufacturer of professional dental products and technologies, and 3Shape, a leading innovator of digital solutions... Read more


Bionano Genomics Announces Third OEM Partner has Received China NMPA Approval for DNA Isolation Products for IVD Use of OGM

Bionano original equipment manufacturing (OEM) partner Ecobono obtained reagent Class I registration and approval for Bionano’s DNA isolation kits for optical genome mapping (OGM) from China's National Medical Products Administration (NMPA) Reagents can be utilized for in vitro diagnostics (IVD) use in China With this NMPA registration, Ecobono can sell OGM reagents to independent clinical laboratories and Chinese hospitals SAN DIEGO, Sept. 21, 2023 (GLOBE... Read more


HeartSciences Signs Definitive Agreements with the Icahn School of Medicine at Mount Sinai to Commercialize Artificial Intelligence Cardiovascular Algorithms

Southlake, TX, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an AI-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced it has executed definitive agreements with the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai), in New York, NY, to commercialize electrocardiographic AI algorithms... Read more


ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System

IRVINE, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the signing of an exclusive, royalty-bearing license agreement with Biorad Medysis, Pvt. Ltd. (Biorad) to manufacture, commercialize and distribute the Obalon® Gastric Balloon System in India, Pakistan, Bangladesh, Nepal, Bhutan, Sri Lanka, and the Maldives. Based in Mumbai, India, Biorad... Read more


LeMaitre Vascular to Present at the 2023 Cantor Global Healthcare Conference

BURLINGTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at 2023 Cantor Global Healthcare Conference on Tuesday, September 26, 2023, at 11:40 AM ET in New York City. About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, m... Read more


AVITA Medical to Present at the Cantor Global Healthcare Conference

VALENCIA, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announced that Jim Corbett, Chief Executive Officer, will present at the 2023 Cantor Fitzgerald Global Healthcare Conference in New York on Tuesday, September 26, 2023, at 11:05 a.m. Eastern Time. A live webcast... Read more


Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13

TORONTO, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will host an Analyst & Investor Day event on Friday, October 13, 2023 from 1:00 p.m. to approximately 3:30 p.m. Eastern Time. “The program will feature presentations on TULSA-PRO® and its unrivalled... Read more


Sera Prognostics To Present At Cantor Fitzgerald Global Healthcare Conference 2023

SALT LAKE CITY, Sept. 21, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the company will present at the upcoming Cantor Fitzgerald Global Healthcare Conference 2023 to be held September 26-28, 2023 in New York City. Zhenya Lindgardt, Sera's interim President and CEO, is scheduled to... Read more


electroCore to Present at iAccess Alpha’s – Top 10 Best Ideas from the Buyside Virtual Conference

ROCKAWAY, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, will present at iAccess Alpha’s – Top 10 Best Ideas from the Buyside Virtual Conference. Mr. Goldberger will also be available for one-on-one meetings held throughout the conference on September 26 and 27, 2023. iAccess Alpha’s – Top 10 Best Ideas from the Buyside Virtual... Read more


Intelligent Bio Solutions Successfully Debuts Intelligent Fingerprinting Drug Screening Solution at the 2023 Workplace Health & Safety Show in Sydney, Australia

NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful debut of its Intelligent Fingerprinting Drug Screening System at the 2023 Workplace Health & Safety Show in Sydney, Australia on September 20th and 21st. The non-invasive, portable system is designed to enable workplace health... Read more


Helius Medical Technologies to Bring its Innovative PoNS Therapy for Improvement of Gait in People with MS, to the 2023 Academy of Neurologic Physical Therapy Conference

Company’s First-Ever ANPT Booth Sponsorship Enables Specialists to Learn More about this Breakthrough Technology on Eve of National Physical Therapy Month NEWTOWN, Pa., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that it will exhibit at the Academy of Neurologic... Read more


ProSomnus Raises $10 Million To Fuel Growth and Optimize Operations

PLEASANTON, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (“OSA”), today announced the completion of a $10 million convertible preferred equity offering led by existing investors Spring Mountain Capital and Cetus Capital, LLC. ProSomnus’s Executive Chair, Chief Executive Officer, and Chief Financial Officer are also participating in the... Read more


Psychemedics Appoints Shannon Shoemaker as Chief Revenue Officer

ACTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the world’s largest provider of hair testing for drugs of abuse, is pleased to announce the appointment of Shannon Shoemaker as its new Chief Revenue Officer. In this role, Shoemaker will be responsible for overseeing the company's revenue generation and growth strategies. With an exceptional track record of leadership and a strong background in revenue growth and optimization, Shoemaker brings... Read more


Quantum-Si Appoints Biotech Executive and Entrepreneur, Amir Jafri, to its Board of Directors

BRANFORD, Conn. / Sep 21, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Amir Jafri, President and CEO of Immunicom, Inc., to its Board of Directors. “Amir’s leadership track record speaks for itself,” said Jeff Hawkins, CEO of Quantum-Si. “He has successfully managed businesses across multiple industries and has built and led world... Read more


Femasys Announces First-Patient-In for Pivotal Clinical Trial Evaluating its FemBloc Permanent Birth Control

ATLANTA, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including two lead revolutionary late-clinical stage product candidates and FDA-cleared, innovative diagnostic products, today announced the achievement of First-Patient-In for its pivotal clinical trial evaluating FemBloc®, a first-of-its-kind, non-surgical,... Read more


Abbott Broadens Access to Cutting-Edge Biosimilars in Key Emerging Markets

Abbott to commercialize several biosimilar molecules in key emerging markets in Latin America, Southeast Asia, the Middle East and Africa Spain-based global biotech leader mAbxience Holdings S.L. to develop, manufacture and supply the biosimilar molecules First molecules expected to launch as early as 2025, offering new treatment options that leverage the latest in scientific breakthroughs for people in emerging markets ABBOTT PARK, Ill., Sept. 20, 2023 /PRNewswire/... Read more


Waters ZetaStar Instrument Boosts Speed and Sensitivity of Light Scattering Measurements for Biological Therapies

News Summary: New Zeta Star™ instrument for nanoparticle analysis from Wyatt Technology™ portfolio combines three light scattering techniques into a single device – cutting measurement time by up to 10x[i] over other methods. Measures biologic drug products at extremely low sample volumes to determine five critical parameters within one workflow, increasing efficiency, and also improves confidence in results. ZetaStar instrument supports workflows in gene therapy,... Read more


ICON Releases Expanded End-to-end Clinical Trial Tokenisation Solution

Solution seamlessly delivers proprietary technology, real world data and analytics, aligning to industry security and data privacy standards DUBLIN / Sep 20, 2023 / Business Wire / ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announces the release of its next generation Clinical Trial Tokenisation solution. The combination of ICON’s proprietary tokenisation engine, access to real-world data and advanced... Read more


Orthofix Medical Announces First Patient Procedures and Full Commercial Launch of the Galaxy Fixation Gemini System and Expanded Sterile Kit Offerings for Orthopedic Trauma Procedures

LEWISVILLE, Texas / Sep 20, 2023 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full U.S. commercial launch and successful completion of the first cases with the Galaxy Fixation Gemini™ system. The latest in the Galaxy product line, this stable external fixation system is provided in several sterile procedure kit configurations as a quick off-the-shelf solution for treating fractures that result... Read more


IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer

CAESAREA, Israel, Sept. 20, 2023 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that the U.S. Food and Drug Administration ("FDA") has at this time denied the Company's De Novo Classification request for breast cancer which was submitted based on interim analysis from its ICE3 study. The... Read more


BrainsWay Broadens Access to Deep TMS™ for U.S. Military Service Members Through Expanded Partnership with Katie’s Way Plus

BURLINGTON, Mass. and JERUSALEM, Sept. 20, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that its longstanding partner, Katie’s Way Plus, which provides comprehensive mental health services tailored to the unique needs of active duty military members, veterans, and their families, has ordered an additional... Read more


NuGen Medical Devices Completes Delivery and First Sale of 500 InsuJet(TM) Devices and Consumables in Romania

Toronto, Ontario--(Newsfile Corp. - September 20, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to report it has completed the delivery and sale of the first 500 units of the Company's needle-free InsuJet™ injector device and consumables to SC Trustmed SRL ("Trustmed") in Romania as previously announced on June 12th, 2023. The sale, although small in size, was completed earlier than anticipated and represents a milestone for NuGen... Read more


Helius Medical Technologies: University of Montreal’s School of Rehabilitation to Purchase Ten PoNS® Devices for Research Study on Stroke Recovery

NEWTOWN, Pa., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced it has signed an agreement with the School of Rehabilitation at the Université de Montréal (“UdeM”) for the purchase of ten PoNS devices to be used in a research project linked to stroke recovery. “We... Read more


Charles River Laboratories to Host Virtual Investor Day

WILMINGTON, Mass. / Sep 20, 2023 / Business Wire / Charles River Laboratories International, Inc. (NYSE: CRL) announced that it will host a virtual Meeting with Management on Thursday, September 21st, beginning at 8:30 a.m. ET. This virtual event will feature presentations from its senior management team, including an overview of the Company’s strategic focus, business developments, and updated financial targets, with a focus on the progress of its environmental, social,... Read more


Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe

FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, is furthering its mission to advance the next generation of high parameter cell analysis by continuing to have an active presence at key industry events worldwide. The company’s Full Spectrum Profiling™ (FSP™) technology that streamlines workflows, accelerates discoveries and maximizes efficiency will be front and center at both the... Read more


Treace Medical Concepts Highlights New Product Innovations and Updated ALIGN3D™ Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2023

PONTE VEDRA, Fla., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions) through its Lapiplasty® 3D Bunion Correction® Procedure, today announced it will highlight new product innovations and present new interim data for the ALIGN3D™ clinical study at the American Orthopaedic... Read more


Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference 

BERKELEY, Calif. and MAINZ, Germany, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that Guido Baechler, Chief Executive Officer, will present at the Cantor Fitzgerald Global Healthcare Conference which takes place September 26-28, 2023 in New York City. This year’s conference is expected to bring together... Read more


Atrion Announces Election of New Director

ALLEN, Texas, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) announced the election today of Jeannette Bankes as a director, effective immediately. Ms. Bankes brings to our Board over 32 years of experience at major medical device and pharmaceutical companies. Since March 2019, Ms. Bankes has served as the President and General Manager of the Global Surgical Franchise at Alcon Inc. From August 2004 to March 2019, Ms. Bankes served in leadership positions... Read more


Great Elm Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results

WALTHAM, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Great Elm Group, Inc. (“we,” “our,” “GEG,” “Great Elm,” or “the Company”), (NASDAQ: GEG), an alternative asset manager, today announced financial results for its fiscal fourth quarter and year ended June 30, 2023. Fiscal Fourth Quarter 2023 Highlights GEG collected incentive fees from Great Elm Capital Corp. (“GECC") for the first time in the Company’s history, totaling $1.0 million for the fourth... Read more


T2 Biosystems Receives FDA 510(k) Clearance for the T2Biothreat Panel

LEXINGTON, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the T2Biothreat™ Panel. The FDA 510(k) clearance allows the company to immediately begin marketing and selling the T2Biothreat Panel in the U.S. market. The T2Biothreat Panel is... Read more


Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions

Stryker’s PROstep MIS portfolio will be featured at the American Orthopaedic Foot & Ankle Society Annual Meeting KALAMAZOO, Mich. / Sep 19, 2023 / Business Wire / Stryker (NYSE: SYK), one of the world’s leading medical technology companies, announced the launch of PROstep® MIS Lapidus, a new internal fixation system intended for treating bunions using a minimally invasive surgical reduction of hallux valgus deformity and subsequent fusion of the first metatarsal... Read more


Danaher to Provide Cepheid's Tuberculosis Test to the Global Fund at Cost

New agreement aims to provide greater access to millions more high-quality tuberculosis (TB) tests for people living in the least developed countries where the need is most urgent. Enables the Global Fund to provide Cepheid's Xpert® MTB/RIF Ultra diagnostic test cartridges for TB at cost, with no profit to Danaher. WASHINGTON, Sept. 19, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology innovator, today announced it... Read more


Boston Scientific Announces Agreement to Acquire Relievant Medsystems

Acquisition intended to expand neuromodulation portfolio to provide more treatment options for people living with chronic low back pain MARLBOROUGH, Mass., Sept. 19, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that has developed and commercialized the Intracept® Intraosseous Nerve Ablation System to treat... Read more


Abbott and WeightWatchers Connected App Experience is Now Available for People Living with Diabetes

The #1 prescribed continuous glucose monitoring (CGM) system1 now connects to the #1 doctor-recommended weight management plan2 to help people living with diabetes understand how food and activity impact their glucose levels WeightWatchers Diabetes-Tailored Plan members can now see key glucose data3,4,5 from Abbott's FreeStyle Libre® 2 system within the WW app6 ABBOTT PARK, Ill. and NEW YORK, Sept. 19, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) and WW International,... Read more


Canadian First - Abbott's TactiFlex™ Ablation Catheter Used to Treat AFib

Abbott introduced the world's first ablation catheter with a flexible tip and contact force technology, used to perform an ablation procedure to treat atrial fibrillation (AFib) First successful treatment in Canada - Abbott's innovative technology enables physicians to have better visualization allowing for more accuracy and precision, leading to reduced procedure times and better safety MISSISSAUGA, ON, Sept. 19, 2023 /CNW/ -- Abbott (NYSE: ABT) today announced that... Read more


Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

SALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted therapies. Under the strategic partnership, Myriad and Illumina are working together to advance comprehensive... Read more


Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.

UPPSALA, Sweden, September 19, 2023 (GLOBE NEWSWIRE) – Olink Holding AB (publ) (Nasdaq: OLK) today announced the introduction of Olink® Target 48 Mouse Cytokine Panel, a validated multiplexed protein panel that offers a detailed view of the murine immune system, enabling in-depth disease modelling, longitudinal studies and translational research. The Olink Target 48 Mouse Cytokine Panel represents a new standard in immunoassays giving researchers the ability to accurately... Read more


Akoya Biosciences Sets a New Standard for Scaling Spatial Biology with the Launch of 2.0 Platforms

PhenoCycler-Fusion 2.0 enhancements enable the highest throughput workflow for spatial discovery studies. PhenoImager HT 2.0 delivers a 5x greater speed improvement for spatial studies in translational and clinical research. MARLBOROUGH, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today highlighted the industry-leading scale and speed in whole-slide, spatial biology workflows enabled... Read more


DermTech Announces Contracts With Highmark for the Foundational Assay of Its DermTech Melanoma Test (DMT)

SAN DIEGO / Sep 19, 2023 / Business Wire / DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced agreements with Highmark Inc. (Highmark). The contracts, which are in addition to a favorable coverage policy, enhance access to the foundational assay of the DermTech Melanoma Test (DMT). Highmark and its Blue-branded affiliates provide health insurance to approximately 7... Read more


bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services

Transformative Strategic Transaction Supports Commercialization of CyPath® Lung Precision Pathology Founder Dr. Roby Joyce Joins bioAffinity’s Board of Directors Conference Call at 4:30 p.m. Eastern time Today SAN ANTONIO, Texas / Sep 19, 2023 / Business Wire / bioAffinity Technologies, Inc. (Nasdaq: BIAF, BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer, announces the acquisition of the laboratory assets of... Read more


ReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon System

IRVINE, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the company has significantly strengthened the patent portfolio related to its Obalon® Balloon System. Specifically, the U.S. Patent and Trademark Office (USPTO) has granted one patent and provided the company with a Notice of Allowance for two additional patents, providing foundational... Read more


Align Technology Connects With Over 1,000 Doctors and Practice Staff at the 2023 Invisalign™ GP Summit Where Leaders in Digital Orthodontics and Restorative Dentistry Share Best Practices for Leading...

Company Features Latest Innovations Across the Align Digital Platform™ Designed to Provide a Seamless Experience and Workflow that Integrates and Connects all Users – Doctors, Labs, Patients, and Consumers LAS VEGAS & SAN JOSE, Calif. & TEMPE, Ariz. / Sep 19, 2023 / Business Wire / Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero™... Read more


Zynex to Present at the Cantor Global Healthcare Conference

ENGLEWOOD, Colo., Sept. 19, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced it will present at the upcoming Cantor Global Healthcare Conference, which is being held September 26th-28th, 2023. Zynex's presentation will be held in person and webcast live on September 26th at 1:35 PM... Read more


Bioventus to Present at the Cantor Global Healthcare Conference

DURHAM, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and chief financial officer, will participate in a fireside chat at the Cantor Global Healthcare Conference on Thursday, September 28, 2023, at 1:50 p.m. ET. A live audio webcast of the fireside chat will be available on the “Investors” section of the Company’s website at www.... Read more


CareDx To Present at the 2023 Cantor Global Healthcare Conference

BRISBANE, Calif. / Sep 19, 2023 / Business Wire / CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company will participate in the 2023 Cantor Global Healthcare Conference. CareDx’s management is scheduled to present at the 2023 Cantor Global Healthcare Conference... Read more

COPYRIGHT ©2023 HEALTH STOCKS HUB